Abate Kristin 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Abate Kristin
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-03$6.78/sh−12$81→ 9,463 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.